Download presentation
Presentation is loading. Please wait.
Published byCaroline Andreassen Modified over 5 years ago
1
Toxicities and Outcomes for Patients with CNS Lymphoma (CNSL) Consolidated with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT-ASCT) Using Thiotepa, Pharmacokinetically-Targeted (PK) Busulfan (Bu), Cyclophosphamide (TBC) Conditioning Michael Scordo, MD, Valkal Bhatt, PharmD, Meier Hsu, MS, Antonio M. Omuro, MD, Matthew J. Matasar, MD MS, Lisa DeAngelis, MD, Parastoo Dahi, MD, Craig H. Moskowitz, MD, Sergio A. Giralt, MD, Craig S. Sauter, MD Biology of Blood and Marrow Transplantation Volume 22, Issue 3, Pages S132-S133 (March 2016) DOI: /j.bbmt Copyright © Terms and Conditions
2
Figure 1 Analysis of Grade 3-5 Non-Hematologic Toxicities
Biology of Blood and Marrow Transplantation , S132-S133DOI: ( /j.bbmt ) Copyright © Terms and Conditions
3
Figure 2 Kaplan-Meier Curves for PFS and OS
Biology of Blood and Marrow Transplantation , S132-S133DOI: ( /j.bbmt ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.